Healthcare

Intellia Therapeutics captured significant market attention on November 16 when the biotechnology firm unveiled groundbreaking clinical trial data for its...

The telehealth sector's rising star, Hims & Hers, has made a dramatic move to demonstrate faith in its own valuation,...

Monday's trading session revealed unusual quiet for healthcare giant UnitedHealth, signaling potential concerns for market participants. The insurance behemoth, typically...

Investors in Palantir Technologies witnessed a puzzling market response on Monday as the data analytics company unveiled two significant strategic...

The telehealth sector faces increasing regulatory scrutiny, and Hims & Hers Health, Inc. is making strategic moves to navigate these...

In a bold move signaling a new era for the pharmacy chain, Walgreens has eliminated paid holiday benefits for all...

Pfizer's recent $7 billion acquisition of biotechnology firm Metsera has triggered a wave of market skepticism rather than celebration. The...

While numerous real estate investment trusts focused on healthcare face ongoing structural challenges, LTC Properties is demonstrating unexpected resilience. The...

Intellia Therapeutics is confronting one of its most severe market downturns following a cascade of negative developments that have severely...

Baxter International Inc. finds its equity trading near annual lows as the medical technology company contends with a confluence of...